Novel Investigative Study on the Anticancer Potential of Plant Extracts and Silver Nanoparticles as Inhibitory Agents for Lung Cancer

Abstract

Emergent therapeutic strategies that merge robust anti-cancer effects with antioxidant attributes are imperative for addressing lung cancer, a prevalent and often fatal ailment. This presentation explores the potential application of Ginkgo biloba silver nanoparticles (GB-AgNPs) and bilobtin as a viable avenue to impede the advancement of lung cancer while concurrently furnishing antioxidative benefits. In the current study, a total of 30 samples were examined from each of the three distinct groups: control, small cell lung cancer, and adenocarcinoma lung cancer. The results of the study indicate that the application of GB-AgNPs and bilobetein led to a significant reduction in elevated protein carbonyl and retinol binding protein (RBP) levels. This suggests that these interventions have the potential to effectively counteract crucial molecular markers linked to the onset and advancement of lung cancer. These findings open up a new and innovative pathway for the development of targeted therapeutic approaches for lung cancer, utilizing natural compounds as potential treatment agents.